Trilipix
These highlights do not include all the information needed to use TRILIPIX safely and effectively. See full prescribing information for TRILIPIX. TRILIPIX (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 2008
bbf3e782-d163-49c8-0e81-4eeabef48190
HUMAN PRESCRIPTION DRUG LABEL
Jun 1, 2021
AbbVie Inc.
DUNS: 078458370
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Fenofibric Acid
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Fenofibric Acid
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Fenofibric Acid
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
Fenofibric Acid
Product Details
FDA regulatory identification and product classification information